- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02706548
Feasibility of the Integrative Medication Self-Management Intervention to Promote Medication Adherence (IMedS)
March 15, 2016 updated by: Jaclyn Schwartz, University of Wisconsin, Milwaukee
Many persons with chronic health conditions fail to take their medications as prescribed, resulting in declines in health and function.
Unfortunately, current interventions for medication nonadherence are not very effective.
This objective of this study is to test a new intervention, the Integrative Medication Self-management (IMedS) intervention to improve medication adherence in adults with chronic health conditions.
Study Overview
Status
Completed
Conditions
Detailed Description
Many persons with chronic health conditions fail to take their medications as prescribed, resulting in declines in health and function.
Objective: The purpose of this study was to perform a phase I feasibility study to understand if an integrated occupational therapy intervention could help people with chronic health conditions improve their adherence to medications.
Method: Using a small-N design, we report single-subject analyses of the medication adherence, behavior counts, and perceptions of medication adherence of participants before and after either an occupational therapy intervention or standard of care intervention.
We used a multiple baseline approach with inter-subject replication, and blinding.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosed with a chronic health condition
- Live in the community
- A medication regimen of 5 or more medications a day recommended by a health care professional
- Independently manage medications
- Difficulty taking medications as prescribed
- Live in the Milwaukee area
Exclusion Criteria:
- Significant cognitive impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Occupational Therapy Intervention Group
Thirty-minute intervention in which the participant and interventionist discuss past medication taking performance, medication-related goals, and strategies to meet goals.
Intervention is enhanced with motivational interviewing and therapeutic use of self.
|
Half of participants received a manualized 30-minute occupational therapy intervention, Integrative Medication Self-Management Intervention (IMedS).
During IMedS, the interventionist and client progress through three steps in which the pair: 1) reflect on past performance of medication management, 2) set a medication goal, and 3) generate strategies to reach the goal.
During strategy generation, the interventionist uses therapeutic use of self and motivational interviewing to help the client self-generate new medication management strategies, specifically addressing 1) altering the activity, 2) advocacy, 3) education, 4) assistive technology, 5) environmental modifications, and 6) securing timely refills.
|
|
Active Comparator: Standard Care Intervention Group
Thirty-minute educational intervention in which the participant and interventionist review a pamphlet on adherence to medication.
|
The standard care educational intervention was a 30-minute pamphlet based educational session.
In the standard care intervention group, participants and interventionist first reviewed the pamphlet, Managing Your Medicines: Our Guide to Effective Medication Management (American Heart Association & American Stroke Association, 2013).
Then, the interventionist engaged in active listening, where she asked open-ended questions about the participant's medication routines and provided simple reflections.
For the standard care procedures, the interventionist was prohibited from providing affirmations, complex reflections, summaries, problem-solving, or suggesting any specific interventions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Medication Adherence
Time Frame: 4 Weeks
|
Daily medication possession ratio via diary
|
4 Weeks
|
|
Self-perceived improvements in ability to mange medications
Time Frame: 4 weeks
|
Participants at the end of the study indicate if they believe that their ability to manage medications has improved, declined, or stayed the same.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Strategies used to manage medications
Time Frame: 4 weeks
|
Number of new strategies in daily life used to manage medications per participant report
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Schwartz JK, Smith RO. Benefits of Student Engagement in Intervention Research. Am J Occup Ther. 2015 Sep-Oct;69 Suppl 2:6912185050p1-6912185050p10. doi: 10.5014/ajot.2015.018200.
- Schwartz JK, Smith RO. Intervention Promoting Medication Adherence: A Randomized, Phase I, Small-N Study. Am J Occup Ther. 2016 Nov/Dec;70(6):7006240010p1-7006240010p11. doi: 10.5014/ajot.2016.021006.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
May 1, 2015
Study Registration Dates
First Submitted
March 8, 2016
First Submitted That Met QC Criteria
March 8, 2016
First Posted (Estimate)
March 11, 2016
Study Record Updates
Last Update Posted (Estimate)
March 17, 2016
Last Update Submitted That Met QC Criteria
March 15, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15.048
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
Single-subject data available in publications
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsCompletedChronic Conditions, Multiple | Chronic ConditionDenmark
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
University of LimerickCompletedChronic Conditions, MultipleIreland
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on Integrative Medication Self Management (IMedS) Intervention
-
Washington University School of MedicineCompleted
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedMultiple Sclerosis | Low Back Pain | Chronic Pain | Muscular Dystrophies | Spinal Cord Injury | Other and Unspecified Amputation Stump ComplicationsUnited States
-
University of North Texas Health Science CenterUniversity of California, San Francisco; University of Minnesota; Walgreens Boots...TerminatedHypertension | Diabetes Mellitus, Type 2 | HIV/AIDSUnited States
-
Washington University School of MedicineCompleted
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Not yet recruitingChronic Obstructive Pulmonary Disease (COPD)
-
Universidad de GranadaCompleted
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)Completed
-
University of North Carolina, Chapel HillCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Aalborg UniversityCompleted
-
Medstar Health Research InstituteSanofi; Bayer; American Diabetes AssociationCompletedDiabetes Mellitus, Type 2 | Medication Adherence | HYPERGLYCEMIAUnited States